{
    "2018-12-03": [
        [
            {
                "time": "2018-12-02",
                "original_text": "乐普医疗：有望借政策东风继续放量 买入评级",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "政策东风",
                        "放量",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "乐普医疗事件点评:一致性评价突破,静待带量采购",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "一致性评价",
                        "带量采购"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "110亿大品种！这家药企再获带量采购入场券",
                "features": {
                    "keywords": [
                        "药企",
                        "带量采购",
                        "入场券"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "上周“同程艺龙”与母婴电商“宝宝树”在港交所上市",
                "features": {
                    "keywords": [
                        "同程艺龙",
                        "宝宝树",
                        "港交所",
                        "上市"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "互联网",
                        "电商"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "11月，共有这些药企的品规通过一致性评价！",
                "features": {
                    "keywords": [
                        "药企",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "34股获券商买入评级，常宝股份目标涨幅达102.64%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "常宝股份",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "【医药】江琦、赵磊：2018年12月月报：正本清源、结构升级，把握创新、升级的确定性方向 - 20181202",
                "features": {
                    "keywords": [
                        "医药",
                        "正本清源",
                        "结构升级",
                        "创新",
                        "升级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "短调无碍板块走强 医药股仍有向上动能",
                "features": {
                    "keywords": [
                        "医药股",
                        "向上动能"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "乐普医疗:氯吡格雷通过一致性评价,国产替代趋势逐渐清晰",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "氯吡格雷",
                        "一致性评价",
                        "国产替代"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}